Keyword: Pharma

News

Aesica Appoints New Product Release Manager

19.08.2014 - Aesica, the global contract development and manufacturing organisation (CDMO), announced the appointment of Adam Burgess to the position of Product Release Manager. His role...

News

Mylan Trims Forecast Due to FDA Approval Delays

12.08.2014 - US generic drugmaker Mylan has shaved the top end of its full-year revenue and earnings forecasts slightly, citing delays in approval from the US Food and Drug Administration for...

News

Carbogen Amcis to Take Over High-Containment Facility

08.08.2014 - Carbogen Amcis, Swiss-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturer, has announced plans to take over operations of a high...

Strategy & Management

Multichannel Excellence: The Competitive Factor for Pharma

30.07.2014 - Proving Marketing's Value - The global pharmaceutical industry continues to evolve from the blockbuster era to the outcome era. This shift entails many changes. Just to name a few...

News

US-UK Deal Creates Expanded Drug Services Player

29.07.2014 - Pharmaceutical services company Packaging Coordinators Inc. (PCI) said it has reached a "definitive agreement" to acquire Penn Pharmaceutical Services based in Tredegar, Wales...

News

Roche Alzheimer's Drug Fails Main Goals in Mid-stage Study

17.07.2014 - Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...

News

Novartis and Banner in Alzheimer’s Genetic Predisposal Study

16.07.2014 - Novartis is collaborating with Phoenix, Arizona-based US non-profit Banner Alzheimer's Institute (BAI) on a clinical study to determine whether two of the Swiss pharmaceutical...

News

Shire to Bow to AbbVie's Sweetened $53 Billion Offer

15.07.2014 - Dublin-based pharmaceutical producer Shire, a specialist in drugs to treat rare diseases, has succumbed to an increased £31 billion ($53 billion) takeover offer from US drugmaker...